Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neurovascular Product Surveillance Registry (NV PSR INSPIRE) Pipeline™ Vantage Embolization Device With Shield Technology™ Post Approval Study (PAS)

NCT06604884 is registered in ClinicalTrials.gov with Medtronic Neurovascular Clinical Affairs as lead sponsor.

NCT NCT06604884
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06604884 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neurovascular Product Surveillance Registry (NV PSR INSPIRE) Pipeline™ Vantage Embolization Device With Shield Technology™ Post Approval Study (PAS)
Lead sponsor
Medtronic Neurovascular Clinical Affairs
Phase
Observational
Overall status
Recruiting
Start date
December 12, 2025
Completion date
September 30, 2033
Enrollment
118 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

intracranial aneurysm